
Stafia-1
CAS No. 2582757-90-0
Stafia-1( —— )
Catalog No. M28612 CAS No. 2582757-90-0
Stafia-1 is a potent STAT5a inhibitor ( IC50=22.2 μM). Stafia-1 displays high selectivity over STAT5b and other STAT family members.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 177 | Get Quote |
![]() ![]() |
10MG | 293 | Get Quote |
![]() ![]() |
25MG | 498 | Get Quote |
![]() ![]() |
50MG | 716 | Get Quote |
![]() ![]() |
100MG | 981 | Get Quote |
![]() ![]() |
500MG | 1998 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameStafia-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionStafia-1 is a potent STAT5a inhibitor ( IC50=22.2 μM). Stafia-1 displays high selectivity over STAT5b and other STAT family members.
-
DescriptionStafia-1 is a potent STAT5a inhibitor ( IC50=22.2 μM). Stafia-1 displays high selectivity over STAT5b and other STAT family members.
-
In VitroStafia-1 shows at least 9-fold selectivity over STAT5b and higher selectivity against other STAT family members.
-
In Vivo——
-
Synonyms——
-
PathwayJAK/STAT Signaling
-
TargetSTAT
-
RecptorNOP receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2582757-90-0
-
Formula Weight506.44
-
Molecular FormulaC24H27O10P
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (493.64 mM)
-
SMILESCOC1=CC(C2=CC(OP(O)(O)=O)=CC(C3=CC(OC)=C(OC)C(OC)=C3)=C2)=CC(OC)=C1OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Thomsen C, Hohlweg R. (8-Naphthalen-1-ylmethyl-4-oxo-1-phenyl-1,3,8-triaza-spiro[4. 5]dec-3-yl)-acetic acid methyl ester (NNC 63-0532) is a novel potent nociceptin receptor agonist. Br J Pharmacol. 2000 Nov;131(5):903-8.
molnova catalog



related products
-
Enzaplatovir
Enzaplatovir (BTA-585) is an orally available fusion inhibitor with antiviral activity for the study of respiratory syncytial virus infections and coronavirus disease (COVID-19) infections.
-
Corosolic acid
Corosolic acid contains anti-angiogenic activity that can suppress FAK signaling induced by angiopoietin-1.
-
KI16
KI16 is a novel small molecules that inhibit STAT3-dependent transcription and function.